{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:09:58Z","timestamp":1788516598484,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"China National Natural Sciences Foundation","doi-asserted-by":"crossref","award":["30630069"],"award-info":[{"award-number":["30630069"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.bcp.2011.08.012","type":"journal-article","created":{"date-parts":[[2011,8,17]],"date-time":"2011-08-17T17:46:10Z","timestamp":1313603170000},"page":"1593-1603","source":"Crossref","is-referenced-by-count":42,"title":["H1, a derivative of Tetrandrine, exerts anti-MDR activity by initiating intrinsic apoptosis pathway and inhibiting the activation of Erk1\/2 and Akt1\/2"],"prefix":"10.1016","volume":"82","author":[{"given":"Ning","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng-Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Guang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2011.08.012_bib0005","first-page":"886","article-title":"Research advances on circumventing tumor multidrug resistance","volume":"22","author":"Miao","year":"2003","journal-title":"Ai Zheng"},{"key":"10.1016\/j.bcp.2011.08.012_bib0010","first-page":"805","article-title":"Tumor chemosensitization strategies based on apoptosis manipulations","volume":"2","author":"Shabbits","year":"2003","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2011.08.012_bib0015","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer","volume":"5","author":"Szakacs","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bcp.2011.08.012_bib0020","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/sj.clpt.6100296","article-title":"Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies","volume":"83","author":"Mimeault","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bcp.2011.08.012_bib0025","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2796.2005.01570.x","article-title":"a basic biological phenomenon with wide-ranging implications in human disease","volume":"258","author":"Fadeel","year":"2005","journal-title":"J Intern Med"},{"key":"10.1016\/j.bcp.2011.08.012_bib0030","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1172\/JCI26321","article-title":"Pharmacological manipulation of cell death: clinical applications in sight?","volume":"115","author":"Green","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2011.08.012_bib0035","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0065-2776(08)60402-2","article-title":"CD95(APO-1\/Fas)-mediated apoptosis: live and let die","volume":"71","author":"Krammer","year":"1999","journal-title":"Adv Immunol"},{"key":"10.1016\/j.bcp.2011.08.012_bib0040","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1044-5323(03)00030-7","article-title":"Function and regulation of the CD95 (APO-1\/Fas) ligand in the immune system","volume":"15","author":"Li-Weber","year":"2003","journal-title":"Semin Immunol"},{"key":"10.1016\/j.bcp.2011.08.012_bib0045","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.1038\/sj.onc.1204750","article-title":"Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer","volume":"20","author":"Fulda","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2011.08.012_bib0050","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1158\/0008-5472.CAN-07-0213","article-title":"Tunicamycin sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response","volume":"67","author":"Jiang","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2011.08.012_bib0055","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/nm1627","article-title":"Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L\/TRAIL","volume":"13","author":"Wagner","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.bcp.2011.08.012_bib0060","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1517\/14728220903136775","article-title":"Targeting the PI3K\/AKT\/mTOR signaling network in acute myelogenous leukemia","volume":"18","author":"Martelli","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.bcp.2011.08.012_bib0065","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","article-title":"Cisplat mode of cytotoxic action molecular basis of resistance","volume":"22","author":"Siddik","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2011.08.012_bib0070","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.2174\/187152009789377772","article-title":"Regulation and importance of the PI3K\/Akt\/mTOR signaling pathway in hematologic malignancies","volume":"9","author":"Kawauchi","year":"2009","journal-title":"Anti-Cancer Agents Med Chem"},{"key":"10.1016\/j.bcp.2011.08.012_bib0075","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/jcb.10751","article-title":"Distinctive regulation and function of PI 3K\/Akt and MAPKs in doxorubicin-induced apoptosis of human lung adenocarcinoma cells","volume":"91","author":"Zhao","year":"2004","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.bcp.2011.08.012_bib0080","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.canlet.2009.06.009","article-title":"Tetrandrine induces apoptosis and growth suppression of colon cancer cells in mice","volume":"287","author":"Wu","year":"2010","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bcp.2011.08.012_bib0085","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1002\/ijc.24208","article-title":"Tetrandrine suppresses tumor growth and angiogenesis of gliomas in rats","volume":"124","author":"Chen","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bcp.2011.08.012_bib0090","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.tips.2004.01.009","article-title":"Herbal alkaloid tetrandrine: fron an ion channel blocker to inhibitor of tumor proliferation","volume":"25","author":"Wang","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bcp.2011.08.012_bib0095","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0024-3205(03)00266-2","article-title":"Tetrandrine-induced cell cycle arrest and apoptosis in Hep G2 cells","volume":"73","author":"Kuo","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.bcp.2011.08.012_bib0100","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00280-004-0868-0","article-title":"Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine","volume":"55","author":"Jin","year":"2005","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.bcp.2011.08.012_bib0105","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00280-010-1397-7","article-title":"H1, a novel derivative of tetrandrine reverse P-glycoprotein-mediated multidrug resistance by inhibiting transport function and expression of P-glycoprotein","volume":"67","author":"Wei","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.bcp.2011.08.012_bib0110","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.bcp.2008.11.007","article-title":"Inhibiting the function of ABCB1 and ABCG2 by the EGFR tyrosine kinase inhibitor AG1478","volume":"77","author":"Shi","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2011.08.012_bib0115","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.abb.2003.08.004","article-title":"Rhein induces apoptosis in HL-60 cells via reactive oxygen species-independent mitochondrial death pathway","volume":"418","author":"Lin","year":"2003","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.bcp.2011.08.012_bib0120","series-title":"Anticancer drug development guide","first-page":"125","article-title":"Human tumor xenograft models in NCI drug development","author":"Alley","year":"2004"},{"key":"10.1016\/j.bcp.2011.08.012_bib0125","first-page":"349","article-title":"Cancer multidrug resistance: a review of recent drug discovery research","volume":"5","author":"Liscovitch","year":"2002","journal-title":"IDrugs"},{"key":"10.1016\/j.bcp.2011.08.012_bib0130","first-page":"1205","article-title":"Advances in the targeting ATP-binding cassette transporters to overcome tumor multi-drug resistance","volume":"45","author":"Wei","year":"2010","journal-title":"Acta Pharm Sin"},{"key":"10.1016\/j.bcp.2011.08.012_bib0135","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.bbamcr.2006.10.001","article-title":"Roles of the Raf\/MEK\/ERK pathway in cell growth, malignant transformation and drug resistance","volume":"1773","author":"McCubrey","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bcp.2011.08.012_bib0140","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1124\/mol.104.001966","article-title":"Regulation of the stability of P-glycoprotein by ubiquitination","volume":"66","author":"Zhang","year":"2004","journal-title":"Mol Pharmacol"},{"issue":"Suppl. 2","key":"10.1016\/j.bcp.2011.08.012_bib0145","first-page":"S11","article-title":"Resistance and relapse with imatinib in CML: causes and consequences","volume":"6","author":"Deininger","year":"2008","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.bcp.2011.08.012_bib0150","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1368-7646(03)00024-4","article-title":"The interface between ErbB and non-ErbB receptors in tumor invasion: clinical implications and opportunities for target discovery","volume":"6","author":"Alaoui-Jamali","year":"2003","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.bcp.2011.08.012_bib0155","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1021\/jm9604080","article-title":"Syntheses and structure\u2013activity relationships of the second-generation antitumor taxoids: exceptional activity against drug-resistant cancer cells","volume":"39","author":"Ojima","year":"1996","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2011.08.012_bib0160","doi-asserted-by":"crossref","first-page":"e4881","DOI":"10.1371\/journal.pone.0004881","article-title":"S9, a novel anticancer agent, exerts its anti-proliferative activity by interfering with both PI3K-Akt-mTOR signaling and microtubule cytoskeleton","volume":"4","author":"Zhang","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2011.08.012_bib0165","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1158\/1078-0432.CCR-08-0550","article-title":"N-(2,6-dimethoxypyridine-3-yl)-9-methylcarbazole-3-sulfonamide as a novel tubulin ligand against human cancer","volume":"14","author":"Wang","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2011.08.012_bib0170","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1158\/1078-0432.CCR-06-0290","article-title":"Predicting cancer drug response by proteomic profiling","volume":"12","author":"Ma","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2011.08.012_bib0175","doi-asserted-by":"crossref","first-page":"9086","DOI":"10.1158\/0008-5472.CAN-04-0313","article-title":"Tetrandrine induces early G1 arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of G1-S-specific cyclin-dependent kinases and by inducing p53 and p21Cip1","volume":"64","author":"Meng","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2011.08.012_bib0180","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1126\/science.1062236","article-title":"Controlling the caspases","volume":"294","author":"Fesik","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bcp.2011.08.012_bib0185","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/ncb1203-1041","article-title":"Calcium orchestrates apoptosis","volume":"5","author":"Mattson","year":"2003","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.bcp.2011.08.012_bib0190","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/sj.cdd.4401949","article-title":"Is MAC the knife that cuts cytochrome c from mitochondria during apoptosis?","volume":"13","author":"Dejean","year":"2006","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.bcp.2011.08.012_bib0195","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.bbabio.2010.01.007","article-title":"MAC and Bcl-2 family proteins conspire in a deadly plot","volume":"1797","author":"Dejean","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bcp.2011.08.012_bib0200","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bbadis.2005.07.002","article-title":"Regulation of the mitochondrial apoptosis-induced channel, MAC, by BCL-2 family proteins","volume":"1762","author":"Dejean","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bcp.2011.08.012_bib0205","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0006-2952(03)00397-6","article-title":"Induction of apoptosis in human hepatoblastoma cells by tetrandrine via caspase-dependent Bid cleavage and cytochrome c release","volume":"66","author":"Oh","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2011.08.012_bib0210","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4142\/jvs.2009.10.1.23","article-title":"Synergistic effect of ERK inhibition on tetrandrine-induced apoptosis in A549 human lung carcinoma cells","volume":"10","author":"Cho","year":"2009","journal-title":"J Vet Sci"},{"key":"10.1016\/j.bcp.2011.08.012_bib0215","first-page":"24","volume":"292","author":"Liu","year":"2010","journal-title":"5-Bromotetrandrine enhances the sensitivity of doxorubicin-induced apoptosis in intrinsic resistant human hepatic cancer Bel7402 cells. Cancer letters"},{"key":"10.1016\/j.bcp.2011.08.012_bib0220","first-page":"639","article-title":"Modulation of bcl-2 family proteins in MAPK independent apoptosis induced by a cdc25 phosphatase inhibitor Cpd 5 in renal cancer cells","volume":"14","author":"Mizuno","year":"2005","journal-title":"Oncol Rep"},{"key":"10.1016\/j.bcp.2011.08.012_bib0225","doi-asserted-by":"crossref","first-page":"21085","DOI":"10.1074\/jbc.M400063200","article-title":"Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils","volume":"279","author":"Gardai","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2011.08.012_bib0230","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: navigating downstream","volume":"129","author":"Manning","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2011.08.012_bib0245","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/ijc.25817","article-title":"Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma","volume":"129","author":"Liu","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bcp.2011.08.012_bib0240","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.canlet.2008.03.059","article-title":"Anticancer effect of tetrandrine on primary cancer cells isolated from ascites and pleural fluids","volume":"268","author":"Liu","year":"2008","journal-title":"Cancer Lett"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295211006617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295211006617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T12:53:18Z","timestamp":1543582398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295211006617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0006295211006617"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2011.08.012","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}